Home Pilots AION Labs launches CombinAble.AI to design antibodies for therapeutic development Pilots AION Labs launches CombinAble.AI to design antibodies for therapeutic development By - March 15, 2024 78 0 Facebook Twitter Pinterest WhatsApp The Israel-based company is the result of AION Labs’ fifth startup challenge. RELATED ARTICLESMORE FROM AUTHOR Pilots University of New South Wales trials brain game for chronic pain treatment Pilots Hims & Hers Health acquires European telemedicine platform Zava Pilots Emerging technologies in healthcare, part 2: General Catalyst LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Workers compensation platform Bardavon Health Innovations scoops up digital MSK startup PeerWell Pilots - June 15, 2022 0 MediBuddy buys Aetna’s telehealth biz in India Pilots - February 10, 2023 0 Value-based care platform Vytalize Health raises $100M Pilots - February 23, 2023 0 Maven Clinic, Amazon partner to offer women’s healthcare to Amazon employees Pilots - August 8, 2023 0 Inato raises $20M to expand clinical trial site matching platform Pilots - March 29, 2023 0 POPULAR CATEGORIESPilots2365Applications834Testing285Collaborations15GitHub3